Fermentalg SA (LON:0QTJ)

Market Cap	37.78M -6.9%
Revenue (ttm)	11.68M +16.4%
Net Income	-8.23M
EPS	-0.08
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12
Open	0.4895
Previous Close	0.4980
Day's Range	0.4895 - 0.4895
52-Week Range	0.4100 - 0.6380
Beta	1.06
Analysts	n/a
Price Target	n/a
Earnings Date	May 5, 2026

About Fermentalg

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2009
• Employees: 63
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QTJ

Financial Performance

In 2025, Fermentalg's revenue was 13.38 million, an increase of 16.41% compared to the previous year's 11.50 million. Losses were -9.44 million, -26.71% less than in 2024.

Financial numbers in EUR